Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Q: What does CUSIP 92840H400 represent in this 13F holders report?

CUSIP 92840H400 is the security identifier for VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2023?

30 institutional investors reported VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 92840H400

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 39,040,476
Total 13F shares: 966,706
Share change: +966,706
Total reported value: $1,807,113
Price per share: $1.87
Number of holders: 30
Value change: +$1,807,113
Number of buys: 30

Quarterly Holders Quick Answers

What is CUSIP 92840H400?
CUSIP 92840H400 identifies VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023

Recent filing periods for CUSIP 92840H400:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Venrock Healthcare Capital Partners II, L.P.	3/4/5	10%+ Owner	— class O/S missing	20,637,286	$35,434,220	—	12 Jul 2022	3/4/5
BlackRock Finance, Inc.	13F	Company	— class O/S missing	13,202,454	$1,646,346	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	— class O/S missing	6,432,023	$802,073	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	4,942,230	$616,297	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	3,449,805	$430,190	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	1,841,318	$229,613	—	31 Mar 2023	13F
H. Ralph Snodgrass	3/4/5	PRES./CHIEF SCIENTIFIC OFFICER	— class O/S missing	98,859	$169,741	—	31 Dec 2021	3/4/5
GSA CAPITAL PARTNERS LLP	13F	Company	— class O/S missing	1,275,215	$159,000	—	31 Mar 2023	13F
MAI Capital Management	13F	Company	— class O/S missing	584,925	$72,940	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	— class O/S missing	579,081	$72,212	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— class O/S missing	494,520	$61,667	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	— class O/S missing	331,287	$41,311	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	— class O/S missing	315,900	$39,393	—	31 Mar 2023	13F
Mark Alan Smith	3/4/5	CHIEF MEDICAL OFFICER	— class O/S missing	19,915	$34,194	—	30 Jun 2022	3/4/5
RHUMBLINE ADVISERS	13F	Company	— class O/S missing	258,749	$32,000	—	31 Mar 2023	13F
GPS Wealth Strategies Group, LLC	13F	Company	— class O/S missing	253,205	$31,575	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	— class O/S missing	252,033	$31,505	—	31 Mar 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	— class O/S missing	212,443	$26,491	—	31 Mar 2023	13F
Henrickson Nauta Wealth Advisors, Inc.	13F	Company	— class O/S missing	200,000	$24,940	—	31 Mar 2023	13F
UBS Group AG	13F	Company	— class O/S missing	197,268	$24,659	—	31 Mar 2023	13F
JOHNSON & JOHNSON	13F	Company	— class O/S missing	190,494	$23,755	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	— class O/S missing	183,153	$22,838	—	31 Mar 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	— class O/S missing	180,504	$22,509	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	158,531	$20,000	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	141,567	$17,654	—	31 Mar 2023	13F
TKG Advisors, LLC	13F	Company	— class O/S missing	134,860	$16,817	—	31 Mar 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	— class O/S missing	133,868	$16,693	—	31 Mar 2023	13F
HighTower Advisors, LLC	13F	Company	— class O/S missing	121,273	$15,000	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	120,249	$14,995	—	31 Mar 2023	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	— class O/S missing	109,190	$13,616	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	— class O/S missing	105,128	$13,109	—	31 Mar 2023	13F
Parallax Volatility Advisers, L.P.	13F	Company	— class O/S missing	105,107	$13,107	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	106,446	$13,000	—	31 Mar 2023	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	— class O/S missing	99,879	$12,455	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	— class O/S missing	98,721	$12,310	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	97,669	$12,179	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	— class O/S missing	96,200	$11,996	—	31 Mar 2023	13F
Performa Ltd (US), LLC	13F	Company	— class O/S missing	90,000	$11,223	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	82,259	$10,201	—	31 Mar 2023	13F
SG Americas Securities, LLC	13F	Company	— class O/S missing	81,598	$10,000	—	31 Mar 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	— class O/S missing	76,941	$9,595	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	— class O/S missing	76,721	$9,567	—	31 Mar 2023	13F
FMR LLC	13F	Company	— class O/S missing	72,343	$9,021	—	31 Mar 2023	13F
Neuberger Berman Group LLC	13F	Company	— class O/S missing	67,530	$8,421	—	31 Mar 2023	13F
D.A. DAVIDSON & CO.	13F	Company	— class O/S missing	66,500	$8,293	—	31 Mar 2023	13F
Advisors Capital Management, LLC	13F	Company	— class O/S missing	65,000	$8,000	—	31 Mar 2023	13F
MONETA GROUP INVESTMENT ADVISORS LLC	13F	Company	— class O/S missing	50,682	$6,320	—	31 Mar 2023	13F
Jerrold Duane Dotson	3/4/5	VP, CFO	— class O/S missing	3,671	$6,303	—	30 Jun 2023	3/4/5
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	— class O/S missing	33,959	$5,000	—	31 Mar 2023	13F
TWO SIGMA SECURITIES, LLC	13F	Company	— class O/S missing	34,939	$4,357	—	31 Mar 2023	13F

Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) as of Q2 2023

As of 30 Jun 2023, Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 966,706 shares. The largest 10 holders included VANGUARD GROUP INC, GSA CAPITAL PARTNERS LLP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, Y-Intercept (Hong Kong) Ltd, Cubist Systematic Strategies, LLC, RHUMBLINE ADVISERS, and STATE STREET CORP. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2023 holders

Holder diff

-23

Investor	Q4 2025 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.